IDTechEx Research Details Opportunities and Challenges of Artificial Intelligence in Robotic Surgery

BOSTON, Aug. 24, 2020 /PRNewswire/ — In its recently published report “Innovations in Robotic Surgery 2020-2030: Technologies, Players & Markets“, IDTechEx reports that the robotic surgery market will reach over $12 billion by 2030. The report breaks down the market landscape and emerging technologies in the field of robotic surgery.

The rapid progress of artificial intelligence (AI) technologies in the last 5-10 years has led many to associate it with robotic surgery systems. Currently, however, few robotic surgery systems are equipped with AI-driven human-robot interaction capabilities.

AI offers numerous opportunities for the advancement of robotic surgery. It can facilitate interaction mediums between surgeons and surgical robots, for example by recognizing surgeons’ movements (e.g. head, eyes, hand) and converting them into an action command for the surgical robot. AI can also enable verbal manipulation of a surgical robot through speech recognition arm. Although the precision and the accuracy of speech recognition has improved with the integration of deep learning in speech recognition, this type of technology remains in its early stages and requires further development to become reliable.

AI facilitates robotic instrument positioning. For example, ML algorithms in orthopedic surgery robots allow pre-operative planning by building a virtual model of the patient’s anatomy and enable the creation of a trajectory for intervention (e.g. drilling, screw implantation). This reduces the chance of human error.

So, when will AI become widely implemented in robotic surgery systems? Currently, its use is restricted to image recognition algorithms for pre-operative planning. There is currently no clear path for other forms of AI in robotic surgery.

Regulations are the biggest roadblock. Regulatory frameworks are not built to accommodate adaptive technologies such as AI because AI algorithms constantly learn and change. When an algorithm adapts, it is no longer the same algorithm and cannot be utilized in the medical practice without updating approvals. While their understanding of AI remains vague, regulatory bodies view this unpredictability as too risky to approve for a surgical robot. They are in the process of designing new methods to regulate AI, but this will take years to come into effect.

To find out more on the use of AI in robotic surgery, please refer to the IDTechEx report “Innovations in Robotic Surgery 2020-2030: Technologies, Players & Markets“. IDTechEx’s findings are not restricted to AI only and cover the entire robotic surgery industry. The report breaks down the market landscape and emerging technologies, highlights the latest trends and provides market forecasts for the next decade.

For more information on this report, please visit www.IDTechEx.com/RoSurgery or for the full portfolio of related research available from IDTechEx please visit www.IDTechEx.com/Research.

IDTechEx guides your strategic business decisions through its Research, Consultancy and Event products, helping you profit from emerging technologies. For more information on IDTechEx Research and Consultancy, contact research@IDTechEx.com or visit www.IDTechEx.com.

Media Contact:

Natalie Moreton
Digital Marketing Manager 
press@IDTechEx.com 
+44(0)1223 812300

View original content:http://www.prnewswire.com/news-releases/idtechex-research-details-opportunities-and-challenges-of-artificial-intelligence-in-robotic-surgery-301117152.html

SOURCE IDTechEx

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

1 day ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

2 days ago